Visium Technologies, Inc. Names New Board Member


Fairfax VA, Oct. 17, 2018 (GLOBE NEWSWIRE) -- Visium Technologies, Inc., announced today the appointment of a new member to its Board of Directors. Dr. Emmanuel Esaka resumes his position immediately.

“We are thrilled to have Dr. Esaka’s expertise on our Board,” said Mark Lucky, Visium’s Chairman of the Board. “He brings a wealth of knowledge from the medical field as well as an entrepreneurial background and considerable management leadership skills. The rapid spread of connected medical devices has left the health care sector increasingly exposed to cyberattacks. With the growing need to provide cybersecurity to the medical field, Dr. Esaka’s addition to the board is invaluable as we enter the next phase of Visium’s global growth.”

Dr. Esaka earned an MBA from Auburn University, and graduated Cum Laude with Highest Honors from Università Degli Studi di Bologna, Italy School of Medicine and Surgery. He is the Founder, Owner, and CEO of Advanced Care Obstetrics and Gynecology PA in Wilmington, Delaware, Co-Founder and Managing Director of 3N Pharma USA, Inc., Founder and CEO of Cameroon American Health System, Inc., and Co-Founder of Caritas Home Health Services, Inc. Dr. Esaka is currently an Attending Obstetrician and Gynecologist at the Christiana Care Health System in Newark, Delaware. He also served as Attending Obstetrician and Gynecologist at Irwin Army Community Hospital in Fort Riley, Kansas. He serves as a Board Director of Meiger Health, Inc.

The Visium board moves from three to four members.

About Visium Technologies, Inc.

Visium Technologies, Inc. (OTCPink: VISM) is a Virginia based company focused on providing innovative cybersecurity solutions to businesses which protect and secure the operating landscape of the enterprise and their data assets. Our focus is on test and measurement (T&M), test and evaluation (T&E), and cybersecurity solutions to protect connected devices (Internet of Things, or “IoT” and Industrial Internet of Things “IIoT”). This includes securing industrial systems from penetration. We do this through a proprietary IoT test platform which we call the Cyber Physical Test Bench (“CPTB”), and by visualizing and prioritizing remediation of technology risks.

For more information please visit and

Safe Harbor Statement: Under the Private Securities Litigation Reform Act of 1995: This release includes forward-looking statements that reflect management's current views with respect to future events and performance. These forward-looking statements are based on management's beliefs and assumptions and information currently available. The words "believe," "expect," "anticipate," "intend," "estimate," "project" and similar expressions that do not relate solely to historical matters identify forward-looking statements. Investors should be cautious in relying on forward-looking statements because they are subject to a variety of risks, uncertainties, and other factors that could cause actual results to differ materially from those expressed in any such forward-looking statements. These factors include, but are not limited to, whether the reverse stock split will be beneficial to the Company and its shareholders, any inability to meet the NYSE American continued listing standards in the future for any reason, and those other factors described in our filings with the U.S. Securities and Exchange Commission. Any responsibility to update forward-looking statements is expressly disclaimed.


Contact Data